OMass Therapeutics Alternatives & Competitors

9 companies similar to OMass Therapeutics — OMass Therapeutics uses high-resolution mass spectrometry to discover drugs, tar...

Atavistik Bio

Precision allosteric therapeutics inspired by the body’s natural regulators

42 Series B $260.00M

Cambridge, United States

Biotechnology Health Care +3

Compare

Nuclera

Bring rapid protein access to your benchtop with eProtein Discovery

108 Series C $207.83M

Cambridge, United Kingdom

Biotechnology Life Sciences +1

Compare

Refeyn

Accelerating discovery and revolutionizing single-molecule bioanalytics with mass photomet...

166 Series A $30.00M

Oxford, United Kingdom

Biotechnology Life Sciences +1

AQEMIA

Scale drug discovery with quantum-inspired physics and generative AI

87 $115.18M

Paris, France

AI Biotechnology +3

Track all OMass Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Eurofins Genomics Americas

Honoring the Science of Life

Louisville, United States

Biotechnology Life Sciences +1

Atrandi Biosciences

Semi-Permeable Capsules (SPCs) for single-cell analysis and multiomics at scale

79 Series A $30.80M

Vilnius, Lithuania

Biotechnology Life Sciences +1

Frontier Medicines

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...

81 Series C $255.50M

South San Francisco, Unit...

Biopharma Biotechnology +2

BenchSci

We empower scientists with the world’s most advanced biomedical artificial intelligence.

242 Series D+ $203.11M

Toronto, Canada

AI Biotechnology +3

Sphere Fluidics Limited

We’re the droplet microfluidic technology company for single cell analysis. We work small...

99 Venture round $47.65M

United Kingdom

Biotechnology Life Sciences +1

About OMass Therapeutics

OMass Therapeutics, founded in 2016 and headquartered in the United Kingdom, stands at the forefront of pharmaceutical innovation, emphasizing its prowess in Life Sciences and Pharmaceutical industries. Harnessing high-resolution mass spectrometry, the company aims to address complex medical needs by discovering novel...

Services

Proprietary biochemistry solutions, Native mass spectrometry integration, Custom chemistry applications

Target Customers

Biotechnology researchers, Pharmaceutical companies, Academic institutions

Business keywords

High-Resolution Mass Spectrometry, Drug Discovery, Pharmaceuticals, Structural Mass Spectrometry, Protein Assemblies, Membrane Receptors, Proprietary Technologies, Severe Unmet Medical Needs, Functional Effect Modulation, Complex Targets, Therapeutics Development, Novel Medicines

Business Model

B2B, B2D, API

Revenue Model

Licensing, Service Fee, Consulting Fee

Frequently Asked Questions

Companies similar to OMass Therapeutics include Atavistik Bio, Nuclera, Refeyn, AQEMIA, Eurofins Genomics Americas. They work in Life Sciences and Pharmaceutical and share OMass Therapeutics's focus on drug discovery.

Bounce Watch lists 9 companies that share OMass Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches OMass Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

OMass Therapeutics Profile Atavistik Bio Alternatives Nuclera Alternatives Refeyn Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at OMass Therapeutics on 11 Mar 2026. The 9 companies listed here were last checked between 11 Mar 2026 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.